CONMED CORPORATION Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Effect (Deprecated 2012-01-31)
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Effect (Deprecated 2012-01-31) of $2.47 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease · last filed 2012-02-28
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, tax effect (deprecated 2012-01-31) for fiscal 2011 was $2.47M.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, tax effect (deprecated 2012-01-31) for fiscal 2010 was -$775.00K, a 1822.22% decline from fiscal 2009.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, tax effect (deprecated 2012-01-31) for fiscal 2009 was $45.00K.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Effect (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $2.47M 10-K · filed 2012-02-28 |
| 2010-12-31 | -$775.00K 10-K · filed 2012-02-28 |
| 2009-12-31 | $45.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |